Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China · Delayed Price · Currency is CNY 21.26
+0.24 (1.14%)
Sep 1, 2026, 4:00 PM EDT
Jiangsu CoWin Biotech Market Cap
Jiangsu CoWin Biotech has a market cap or net worth of 2.34 billion as of September 1, 2026. Its market cap has decreased by -7.77% in one year.
Market Cap
2.34B
Enterprise Value
1.63B
Revenue
219.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.26
ChartMarket Cap Chart
Since October 25, 2022, Jiangsu CoWin Biotech's market cap has decreased from 4.06B to 2.34B, a decrease of -42.49%. That is a compound annual growth rate of -13.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 2.34B | -10.78% |
| Dec 31, 2025 | 2.62B | -17.62% |
| Dec 31, 2024 | 3.18B | -7.26% |
| Dec 29, 2023 | 3.43B | 3.44% |
| Dec 30, 2022 | 3.31B | -18.44% |
| Oct 25, 2022 | 4.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Bioeasy Biotechnology | 2.74B |
| Guangdong VTR Bio-Tech | 2.74B |
| Yantai Zhenghai Biotechnology | 2.74B |
| Landfar Bio-medicine | 2.73B |
| Zhejiang East Asia Pharmaceutical | 2.57B |
| Shanghai Universal Biotech | 2.51B |
| Jilin Jian Yisheng Pharmaceutical | 2.38B |
| Suzhou Fushilai Pharmaceutical | 2.34B |